Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting.
about
Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in micePreparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation.Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.Adding a clearing agent to pretargeting does not lower the tumor accumulation of the effector as predicted.Unexpected side products in the conjugation of an amine-derivatized morpholino oligomer with p-isothiocyanate benzyl DTPA and their removal.A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49.Human islet cell MORF/cMORF pretargeting in a xenogeneic murine transplant modelSuccessful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue.A feasible approach to evaluate the relative reactivity of NHS-ester activated group with primary amine-derivatized DNA analogue and non-derivatized impurity.90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.A novel pretargeting method for measuring antibody internalization in tumor cells.Labeling biomolecules with radiorhenium: a review of the bifunctional chelators.Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibodyDetection of Aspergillus fumigatus pulmonary fungal infections in mice with (99m)Tc-labeled MORF oligomers targeting ribosomal RNAQuantitative Correlation of in Vivo Properties with in Vitro Assay Results: The in Vitro Binding of a Biotin-DNA Analogue Modifier with Streptavidin Predicts the in Vivo Avidin-Induced Clearability of the Analogue-Modified Antibody.Design and evaluation of new Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptides for melanoma imagingIntraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapyAn experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effectorReplacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation.Biodistribution of (99m)tc tricarbonyl glycine oligomers.Comparison between two labeled agents in mice using a coinjection-ratio approach in contrast to a conventional group approach.Radiolabeled oligonucleotides for antisense imaging.Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF.Evaluation of (188)Re-labeled NGR-VEGI protein for radioimaging and radiotherapy in mice bearing human fibrosarcoma HT-1080 xenografts.Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting.Use of Morpholino Oligomers for Pretargeting.A Brief Review of Chelators for Radiolabeling Oligomers.
P2860
Q33944337-1FC80442-A972-4FCD-9525-A8AA6B7A8968Q34014474-4B23509D-7A5F-450B-ADD3-48C360C18697Q34126851-3959F1F3-EF5C-4001-BD61-A20788FDA953Q34519414-EBA458E5-F088-4C9D-BAFA-71924BA149BEQ34644344-1852DF4F-DF28-4F90-B168-E15AEE55E089Q34979175-CEA675E7-1D50-4CE8-9016-E8B80E23C5ABQ35028182-7BE9293A-CAF4-4FD8-BEB9-7C6EF3CB05BFQ35063681-44C2000B-E499-41EA-8FD2-F2F36C25C7CBQ35438592-2C8D0B16-B170-4C74-BA19-560AAF5A82AFQ35629379-42996F6E-8186-4B21-86C8-01C2DEACA950Q35659208-B0203597-35CE-4ED8-AA3A-7176EE33642FQ35942571-A1A5C27B-DAC6-4361-8141-99E320C280A1Q35942576-FAD3CEA9-B119-4692-8E5F-28FA35B91AD3Q35991899-15887C44-932F-4485-BEED-8035764DD2B2Q36445782-6AD0456D-D915-4BF7-B808-F50EB00916AFQ36458382-C14A2D48-DA18-466C-ACAE-3845359ECDD0Q36737564-C07DC2AF-0042-40FD-8D92-29160B633DB4Q36842135-EB22B71F-9D73-49E4-B1AA-D3631A2FE132Q37154201-6465FD64-EEF8-46BE-BE6C-6203EC13B1CCQ37288100-9905CA05-396B-432E-9623-D7264A680151Q37326451-B0F62954-FA49-4508-BDE0-C5234BEA6A1BQ37373494-1479DAFC-55BC-4195-B5AA-09DAC69AADEEQ37913042-D5E488F5-3AA4-4867-9091-FEED1A4E0A5EQ38297700-A10E147B-CEF8-4F77-B933-FDC732E7A759Q38803596-F381B26E-835D-49E0-914F-946CE6297C22Q39958380-162986EB-149D-42F4-8652-8E65AF4AA24FQ50665399-66DB38BD-3BEF-4EA0-9FD6-EFA1110F5A2DQ55426154-5AE5929D-774C-451A-A8A9-8F4F960A2F1F
P2860
Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Radiolabeling of MAG3-morpholi ...... tivity for tumor pretargeting.
@ast
Radiolabeling of MAG3-morpholi ...... tivity for tumor pretargeting.
@en
type
label
Radiolabeling of MAG3-morpholi ...... tivity for tumor pretargeting.
@ast
Radiolabeling of MAG3-morpholi ...... tivity for tumor pretargeting.
@en
prefLabel
Radiolabeling of MAG3-morpholi ...... tivity for tumor pretargeting.
@ast
Radiolabeling of MAG3-morpholi ...... tivity for tumor pretargeting.
@en
P2093
P2860
P1476
Radiolabeling of MAG3-morpholi ...... tivity for tumor pretargeting.
@en
P2093
Donald J Hnatowich
Dongguang Yin
Guozheng Liu
Mary Rusckowski
Shuping Dou
Suresh Gupta
Surong Zhang
P2860
P304
P356
10.1016/J.APRADISO.2006.04.005
P577
2006-05-30T00:00:00Z